Is NCT06127199 recruiting in Berkeley, CA?

Yes, NCT06127199 is currently recruiting participants at its Berkeley, CA location. This contraception clinical trial is actively enrolling qualified participants.

How do I join the contraception clinical trial in Berkeley?

To join this clinical trial in Berkeley, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Berkeley clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Contraception Clinical Trial in Berkeley, CA

Who Can Participate

Inclusion Criteria

Sexually active people assigned female at birth, at risk for pregnancy and desiring contraception.

General good health, by subject history and per investigator judgement

Age 18 through 40 years, inclusive; approximately 66 subjects \>35 years old at visit 2 will be the Enrolled-Eligible Population

In a relationship with a person assigned male at birth who meets eligibility criteria below. --At least 18 years old, not known to be subfertile or infertile

Have regular menstrual cycles (when not on hormonal contraception) with a usual length of 21 to 35 days, without heave bleeding that lasts longer than 5 days

Be willing to stop their current method of contraception (with the exception of condoms) before Visit 2. Participants must experience at least one subsequent menstrual bleed before inserting Ovaprene. Participants using injectable contraception must be at least 9 months post their last dose at screening and have experienced at least 2 subsequent regular menstrual bleeds that were part of cycles of 21-35 days. After stopping their current method of contraception, subjects must either abstain fro vaginal sex or use condoms before inserting their first Ovaprene

Not be actively desiring pregnancy for at least 13 months and be willing to accept an unknown risk of pregnancy

Expect to engage in at least 4 acts of heterosexual vaginal intercourse per cycle during the study.

Be willing to only use Ovaprene as the sole method of contraception over the course of the study

Agree not to participate in any other clinical trials during the course of the study

Be willing and able to comply with study procedures and to return to the clinic for scheduled follow-up visits

Microbiota/innate immunity and colposcopy subsets only:

Be willing to avoid vaginal sex and using tampons and other intravaginal products for 48 hours prior to clinic visits; and be willing to comply with subset procedures

Exclusion Criteria

Currently pregnant and/or have a positive urine pregnancy test at screening.

Have an allergy to the ingredients in Ovaprene

Have a history of toxic shock syndrome

Have a history of hereditary hemochromatosis

Be breastfeeding an infant

Have a history suggestive of infertility, defined as any of the following: known history of ectopic pregnancy or other fertility problem; sterilization/permanent contraception; endometriosis or hospitalization for pelvic inflammatory disease (PID) unless subject has had a subsequent spontaneous intrauterine pregnancy; or use of medications that could cause subfertility such as gonadotropin-releasing hormone agonists

Currently have postcoital bleeding

Have contraindications to pregnancy (medical condition) or chronic use of medications contraindicated in pregnancy

Have a history of clinically significant uterine prolapse, cystocele, or rectocele that has required surgical intervention or pessary use

Positive human immunodeficiency virus (HIV) test at screening

Have exclusionary results on human papilloma virus (HPV) screening/cytology (subjects\>/=21 years old) at screening or require treatment or follow-up for an abnormal Pap smear or HPV test that would be needed during the study.

Have had a vaginal or cervical biopsy within 1 month or vaginal surgery within the 3 months prior to screening

Known current drug or alcohol abuse which, in the opinion of the investigator, could impact study compliance

Have previously been included in the Enrolled-Eligible Population

Is a direct employee or immediate family member of the Sponsor company, site Investigators or study staff

Have taken any investigational drug or used any investigational device within the 30 days prior to screening

Have a history of any severe acute or chronic medical or psychiatric condition or laboratory abnormality that could increase the risk associated with trial participation or study treatment administration or could interfere with the interpretation of trial results

Microbiota/innate immunity subset only: --systemic use in the last 2 weeks prior to screening or anticipated use during the study of antibiotics (other than those used to treat urinary tract infection (UTI), candidiasis, or bacterial vaginosis(BV) diagnosed at Visit 1) or antivirals;

If male partner has or is suspected to have had an HIV infection or other sexually transmitted infection

if male partner has a known sensitivity or allergy to the ingredients in Ovaprene

If male partner has previously participated in this study or has taken any investigational drug or used any investigational device within 30 days prior to the female subject's screening

If the male partner has a history of any severe acute or chronic medical or psychiatric condition that could increase the risk associated with trial participation or could interfere with the interpretation of trial results.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Berkeley?

Yes, this clinical trial (NCT06127199) has an active research site in Berkeley, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Contraception Treatment Options in Berkeley, CA

If you're searching for contraception treatment options in Berkeley, CA, this clinical trial (NCT06127199) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced contraception specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all contraception clinical trials near you to find additional studies recruiting in your area.

Contraception Clinical Trial in Berkeley, CA

Expert Care in Berkeley

IRB Approved

No-Cost Care

Apply for This Berkeley Location

Why Participate?

Simple Process

About This Contraception Study in Berkeley